Search results for "Neoplasms."

showing 10 items of 7882 documents

Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours.

2006

Background: The aims of the present study were to assess the prevalence of HSP27 expression in oral squamous cell carcinoma (OSCC) and to verify whether HSP27 can be considered to be a marker of prognosis in patients with OSCC. Materials and Methods: The immunohistochemical expression of HSP27 was evaluated in 57 OSCC, who received standard treatment and monitoring. After grouping for HSP27 expression, OSCCs were statistically analysed for the variables age, gender, histological grading, TNM, staging and survival rate. Univariate and multivariate analyses were performed. Results: HSP27 was found to be reduced in 31 OSCC and was normally expressed in 26 OSCC. The pattern and intensity of HSP…

squamous cell carcinomaAdultAged 80 and overMaleAdolescentHSP27Middle AgedPrognosissurvivalImmunohistochemistrySurvival RateLogistic ModelsHead and Neck NeoplasmsCarcinoma Squamous CellHumanshead and neck cancerFemaleHeat-Shock ProteinsAgedNeoplasm StagingRetrospective StudiesAnticancer research
researchProduct

Qualitative mucin disorders in patients with primary Sjögren's syndrome:a literature review

2020

Background It is a common opinion that Primary Sjögren Syndrome (pSS) damages the exocrine glands and determines the reduction of secreted saliva, some studies show that there are qualitative anomalies of the mucins produced in saliva, including MUC7, MUC5B, MUC1. The purpose of this study is to trace all the information useful to establish whether there is a qualitative or quantitative defect of the mucins in the pSS. Material and Methods We reviewed the literature by looking for publications relevant to the topic in electronic databases. Sixteen articles met the search criteria. The studies were divided into two categories, those that studied the rheological characteristics of the saliva …

squamous cell carcinomaExocrine glandSalivaSpinnbarkeitMUC1DiseaseReviewMUC5BXerostomiaSalivary Glandsoral diagnosismucinstomatognathic systemMedicineprimary Sjögren's syndrome; mucin; MUC7; MUC5B; MUC1; sulphate oligosaccharidesHumansSalivaGeneral DentistryPathologicalMUC1UNESCO:CIENCIAS MÉDICASOral Medicine and Pathologybusiness.industrymouth neoplasmsMucinMucinsDry mouthprimary Sjögren's syndromestomatognathic diseasesmedicine.anatomical_structureSjogren's SyndromeOtorhinolaryngologyMUC7sulphate oligosaccharidesImmunologySurgerymedicine.symptombusiness
researchProduct

Transformation of proliferative verrucous leukoplakia to oral carcinoma: a ten years follow-up

2004

Los autores presentan un caso de leucoplasia verrugosa proliferativa (LVP) en varón de 78 años de edad. Fue inicialmente presentado como un caso de leucoplasia en lengua pero un estudio microscópico en 1991 reveló la presencia de displasia epitelial leve. Tras 5 años de seguimiento, la lesión sufrió cambios de tamaño y localización y tuvo comportamiento recidivante. En 1996, un área eritematosa granular e indurada que apareció en lengua resultó ser un carcinoma de células escamosas microinvasivo cuando se estudió microscópicamente. Tras una revisión del comportamiento clinicopatológico de esta entidad, los autores concluyeron que se trataba de una leucoplasia verrugosa proliferativa, cuyo d…

squamous cell carcinomaMaleDysplasiamalignant transformationTime FactorsreviewOdontologíapapilomatosishistologycarcinoma de células escamosasclinical examinationEpithelial hyperplasiacase reportfollow upHumanshumandisplasiaPapillomatosisAgedLeucoplasia verrugosa proliferativa:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludproliferative verrucous leukoplakiaCell Transformation Neoplasticepithelium hyperplasialeukoplakiamouth carcinomaUNESCO::CIENCIAS MÉDICASCarcinoma Squamous Cellhiperplasia epitelialMouth NeoplasmsLeukoplakia OralFollow-Up Studies
researchProduct

DNA integrity in diagnosis of premalignant lesions

2020

Background Carcinogenesis is a dynamic process which traditional biopsying can not keep up with. Saliva as fluid in the vicinity of the tumor can offer better insights to this process. This study aimed to identify the accuracy of salivary DNA integrity index in differentiating between oral premalignant lesions and oral cancer. Material and Methods This phase II diagnostic test accuracy study included 93 patients divided into three groups: 30 oral cancer patients, 33 patients with oral premalignant lesions divided into 21 oral lichen planus patients and 12 patients with leukoplakia and 30 normal individuals who acted as controls. Oral rinse was collected from all participants and they all un…

squamous cell carcinomaSalivamedicine.medical_specialtymedicine.disease_causeGastroenterologysurvivalstomatognathic systemmismatch repair endonuclease pms2Oral Cancer and Potentially malignant disordersInternal medicinePositive predicative valuemedicineHumansSalivaGeneral DentistryUNESCO:CIENCIAS MÉDICASLeukoplakiaDna integrityDiagnostic Tests Routinebusiness.industryResearchmouth neoplasmsSignificant differenceCancerDNAmedicine.diseasestomatognathic diseasesOtorhinolaryngologySurgeryOral lichen planusLeukoplakia OralbusinessCarcinogenesisLichen Planus Oral
researchProduct

TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma

2005

To prospectively evaluate the prognostic significance of TP53, H-, K-, and N-Ras mutations, DNA-ploidy and S-phase fraction (SPF) in patients affected by locally advanced laryngeal squamous cell carcinoma (LSCC). Eight-one patients (median follow-up was 71 months) who underwent resective surgery for primary operable locally advanced LSCC were analyzed. Tumor DNA was screened for mutational analysis by PCR/SSCP and sequencing. DNA-ploidy and SPF were performed by flow cytometric analyses. Thirty-six patients (44%) had, at least, a mutation in the TP53 gene. Of them, 22% (8/36) had double mutations and 3% (1/36) had triple mutations. In total, 46 TP53 mutations were observed. The majority (41…

squamous cell carcinomasingle strand conformation polymorphismPrognosipolymerase chain reactionDNA Mutational AnalysisEMTREE drug terms: protein p53 EMTREE medical terms: advanced cancerS PhaseDNA Mutational AnalysiHumansprotein p53 advanced cancer; article; cell cycle S phase; DNA content; exon; flow cytometry; follow up; gene; gene mutation; genetic analysis; histopathology; human; human tissue; larynx carcinoma; multivariate analysis; ploidy; polymerase chain reaction; priority journal; prospective study; single strand conformation polymorphism; squamous cell carcinoma; tp53 gene Carcinoma Squamous Cell; DNA Mutational Analysis; DNA Neoplasm; Genes ras; Humans; Laryngeal Neoplasms; Mutation; Ploidies; Polymorphism Single-Stranded Conformational; Prognosis; S Phase; Survival Rate; Tumor Suppressor Protein p53 [EMTREE drug terms]follow uplarynx carcinomatp53 gene MeSH: Carcinoma Squamous Cellexongene mutationhumanmultivariate analysigeneLaryngeal NeoplasmsPolymorphism Single-Stranded ConformationalLaryngeal NeoplasmPloidiesflow cytometryarticleploidyDNA NeoplasmPrognosisGenes rahuman tissueSurvival RateGenes rascell cycle S phasepriority journalDNA contentgenetic analysiMutationCarcinoma Squamous CellhistopathologyTumor Suppressor Protein p53Ploidieprospective study
researchProduct

Gastrointestinal Stromal Tumors (GISTs)

2021

Gastrointestinal stromal tumors (GISTs) are a group of tumors that, over the past 15 years, has emerged from a poorly understood neoplasm to a well-defined tumor entity. GISTs are highly resistant to conventional chemotherapy and, in the past, were typically managed surgically.

stomatognathic diseasesPathologymedicine.medical_specialtyStromal cellbusiness.industrymedicineConventional chemotherapyNeoplasmGastrointestinal stromal tumors (GISTs)businessmedicine.diseaseneoplasmsdigestive system diseases
researchProduct

The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study

2017

Eik Schiegnitz,1 Peer W Kämmerer,2 Holger Schön,1 Christoph Gülle,1 Manfred Berres,3,4 Keyvan Sagheb,1 Bilal Al-Nawas5 1Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Center, Johannes Gutenberg University of Mainz, Mainz, 2Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre Rostock, Rostock, 3Department of Mathematics and Technology, University of Applied Sciences Koblenz, Remagen, 4Institute of Medical Biometry, Epidemiology and Informatics, Johannes Gutenberg University of Mainz, Mainz, 5Department of Oral and Maxillofacial Surgery, Plastic Surgery, University Medical Centre, Martin-Luther University Ha…

stomatognathic diseasesserum biomarkerOSCCoral premalignant lesionprognosisoral cancerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282OncoTargets and Therapy
researchProduct

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

2020

ABSTRACT Glucocorticosteroids (GCS) have an established role in oncology and are administered to cancer patients in routine clinical care and in drug development trials as co-medication. Given their strong immune-suppressive activity, GCS may interfere with immune-oncology drugs. We are developing a therapeutic cancer vaccine, which is based on a liposomal formulation of tumor-antigen encoding RNA (RNA-LPX) and induces a strong T-cell response both in mice as well as in humans. In this study, we investigated in vivo in mice and in human PBMCs the effect of the commonly used long-acting GCS Dexamethasone (Dexa) on the efficacy of this vaccine format, with a particular focus on antigen-specif…

t-cell primingPremedicationmedicine.medical_treatmentImmunologyPriming (immunology)dexamethasoneglucocorticosteroidsProinflammatory cytokineMice03 medical and health sciences0302 clinical medicineImmune systemAntigenCancer immunotherapyNeoplasmsAnimalsHumansImmunology and AllergyMedicineRC254-282Original ResearchMice Inbred BALB Ccancer immunotherapybusiness.industryrna vaccineImmunityNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC581-607Mice Inbred C57BLCytokineOncology030220 oncology & carcinogenesisImmunologyt-cell vaccineFemaleCancer vaccineImmunologic diseases. AllergybusinessT-cell vaccineResearch Article030215 immunologyOncoImmunology
researchProduct

On the Choice of the Extracellular Vesicles for Therapeutic Purposes

2019

Extracellular vesicles (EVs) are lipid membrane vesicles released by all human cells and are widely recognized to be involved in many cellular processes, both in physiological and pathological conditions. They are mediators of cell-cell communication, at both paracrine and systemic levels, and therefore they are active players in cell differentiation, tissue homeostasis, and organ remodeling. Due to their ability to serve as a cargo for proteins, lipids, and nucleic acids, which often reflects the cellular source, they should be considered the future of the natural nanodelivery of bio-compounds. To date, natural nanovesicles, such as exosomes, have been shown to represent a source of diseas…

theranosticsregenerative medicineReviewexosomesBiologyRegenerative medicineExtracellular vesiclesCatalysisTheranostic NanomedicineCatalysiInorganic Chemistrylcsh:Chemistry03 medical and health sciencesParacrine signallingExtracellular Vesicles0302 clinical medicineDrug Delivery SystemsNeoplasmsAnimalsHumansPhysical and Theoretical ChemistryLipid bilayerMolecular Biologylcsh:QH301-705.5Tissue homeostasisSpectroscopy030304 developmental biology0303 health sciencesDrug CarriersVesicleOrganic ChemistrybiomarkersComputer Science Applications1707 Computer Vision and Pattern RecognitionBiological TransportGeneral MedicineBiomarkerMicrovesiclesnanodelivery3. Good healthComputer Science ApplicationsCell biologyExosomeTheranosticlcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisSignal transductionextracellular vesicles (EVs)Signal TransductionInternational Journal of Molecular Sciences
researchProduct

MTOR inhibitor-based combination therapies for pancreatic cancer

2018

Background: Although the mechanistic target of rapamycin (MTOR) kinase, included in the mTORC1 and mTORC2 signalling hubs, has been demonstrated to be active in a significant fraction of patients with pancreatic ductal adenocarcinoma (PDAC), the value of the kinase as a therapeutic target needs further clarification. Methods: We used Mtor floxed mice to analyse the function of the kinase in context of the pancreas at the genetic level. Using a dual-recombinase system, which is based on the flippase-FRT (Flp-FRT) and Cre-loxP recombination technologies, we generated a novel cellular model, allowing the genetic analysis of MTOR functions in tumour maintenance. Cross-species validation and pha…

therapeutic resistance0301 basic medicineCancer ResearchCell SurvivalMAP Kinase Signaling Systempancreatic cancerAntineoplastic AgentsContext (language use)Mechanistic Target of Rapamycin Complex 2mTORC1Mechanistic Target of Rapamycin Complex 1BiologymTORC2BortezomibMice03 medical and health sciencesCell Line TumorPancreatic cancermedicineAnimalsHumansExtracellular Signal-Regulated MAP KinasesMechanistic target of rapamycinPI3K/AKT/mTOR pathwayBenzoxazolesKinaseMTORTOR Serine-Threonine Kinasesmedicine.diseaseddc:3. Good healthPancreatic NeoplasmsPyrimidines030104 developmental biologyOncologybiology.proteinCancer researchCamptothecinTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinaseTranslational TherapeuticsProto-Oncogene Proteins c-aktBiologieCarcinoma Pancreatic Ductal
researchProduct